Cargando…
Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators
Background: Cancer patients are alleged to have poor coronavirus disease 2019 (COVID-19) outcomes. However, no systematic or comprehensive analyses of the role and mechanisms of COVID-19 receptor-related regulators in cancer are available. Methods: We comprehensively evaluated the genomic alteration...
Autores principales: | Zhang, Jian, Jiang, Huali, Du, Kunpeng, Xie, Tao, Wang, Baiyao, Chen, Chengcong, Cen, Bohong, Yuan, Yawei, Ye, Jiacai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385656/ https://www.ncbi.nlm.nih.gov/pubmed/34458283 http://dx.doi.org/10.3389/fmed.2021.662460 |
Ejemplares similares
-
Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective
por: Khan, Muhammad, et al.
Publicado: (2022) -
A Multi-Omics Pan-Cancer Analysis of 4EBP1 in Cancer Prognosis and Cancer-Associated Fibroblasts Infiltration
por: Du, Kunpeng, et al.
Publicado: (2022) -
C1QTNF6 is a Prognostic Biomarker and Related to Immune Infiltration and Drug Sensitivity: A Pan-Cancer Analysis
por: Liu, Wei, et al.
Publicado: (2022) -
PD-L1 expression as biomarker of efficacy of PD-1/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: A systematic review and meta-analysis
por: Khan, Muhammad, et al.
Publicado: (2023) -
A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma
por: Du, Kunpeng, et al.
Publicado: (2022)